Two novel mutations in ADAMTS13 in a Chinese boy with congenital thrombocytopenic purpura: a case report

被引:3
|
作者
Hou, Ling [1 ]
Du, Yue [1 ]
机构
[1] China Med Univ, Pediat Nephrol Dept, Shengjing Hosp, 36 Sanhao St Heping Dist, Shenyang 110004, Liaoning, Peoples R China
关键词
Congenital thrombotic thrombocytopenic purpura (cTTP); ADAMTS13; Gene mutation; FACTOR-CLEAVING PROTEASE; MOLECULAR CHARACTERIZATION; GENE-MUTATIONS; PATIENT; ADULT; GENOTYPE; FAMILY; DOMAIN; TTP;
D O I
10.1186/s12881-020-00996-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Mutations in the ADAMTS13 gene family have been reported to cause congenital thrombotic thrombocytopenic purpura (cTTP), a rare disease characterized by thrombocytopenia and hemolytic anemia. Nearly 150 causative mutations in ADAMTS13 have been identified; however, only a few of them were detected in Chinese patients. Case presentation A 5-year-old Chinese boy presented with history of thrombocytopenic purpura, hemolytic anemia, and renal injury since the neonatal period. Gene analysis revealed two novel mutations in ADAMTS13: a missense mutation 332G > A (p:Gly111Glu) in exon4 and a nonsense mutation 3121C > T (p:Gln1041stop) in exon 24. Genetic analysis of his parents confirmed the heterozygous nature of the mutations. Conclusion We report two novel mutations in ADAMTS13 (332G > A, 3121C > T) in a Chinese boy. These two mutations may lead to early onset of cTTP and severe symptoms.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura
    Tsai, HM
    BLOOD, 2002, 100 (10) : 3839 - 3840
  • [22] Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor:: in vitro inhibition of ADAMTS13 activity by hemoglobin
    Studt, JD
    Hovinga, JAK
    Antoine, G
    Hermann, M
    Rieger, M
    Scheiflinger, F
    Lämmle, B
    BLOOD, 2005, 105 (02) : 542 - 544
  • [23] Thrombotic thrombocytopenic purpura: The role of ADAMTS13
    Rogers, Heesun J.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2016, 83 (08) : 597 - 603
  • [24] MUTATIONS IN ADAMTS13 GENE IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) IN RUSSIA
    Poznyakova, J.
    Pshenichnikova, O.
    Surin, V.
    Tsvetaeva, N.
    Avdonin, P.
    Stolyar, A.
    Klebanova, E.
    Galstyan, G.
    HAEMOPHILIA, 2021, 27 : 161 - 161
  • [25] Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS)
    Licht, C
    Stapenhorst, L
    Simon, T
    Budde, U
    Schneppenheim, R
    Hoppe, B
    KIDNEY INTERNATIONAL, 2004, 66 (03) : 955 - 958
  • [26] Unusually high ADAMTS13 activity in a patient with congenital thrombotic thrombocytopenic purpura
    Subhan, Maryam Owais
    de Groot, Rens
    Scully, Marie
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (05) : 673 - 675
  • [27] Evolution of ADAMTS13 antibodies in a fatal case of thrombotic thrombocytopenic purpura
    Dong, Lingli
    Chandrasekaran, Visalam
    Zhou, Wenhua
    Tsai, Han-Mou
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (10) : 815 - 817
  • [28] An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations
    Zhou, WH
    Tsai, HM
    THROMBOSIS AND HAEMOSTASIS, 2004, 91 (04) : 806 - 811
  • [29] Congenital thrombotic thrombocytopenic purpura in a large cohort of patients carrying a novel mutation in ADAMTS13 gene
    Pikovsky, Oleg
    Arafat, Maram
    Ovadia, Hilla
    Sharoni, Yoav
    Al-Athamen, Kayed
    Kanengisser-Pines, Bibi
    Keren-Politansky, Anat
    Levi, Itai
    Erez, Offer
    Parvari, Ruti
    Rabinovich, Anat
    THROMBOSIS RESEARCH, 2020, 185 : 167 - 170
  • [30] Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura - Reply
    Kelton, JG
    TRANSFUSION, 2002, 42 (11) : 1524 - 1525